Analyst Ratings January 28, 2026

UBS Lifts Boeing Price Target to $285 Citing Improving Cash Flow and Production Focus

Bank keeps Buy rating as Boeing posts stronger-than-expected Q4 2025 results and analysts raise targets

By Caleb Monroe BA
UBS Lifts Boeing Price Target to $285 Citing Improving Cash Flow and Production Focus
BA

UBS increased its price target for Boeing to $285 from $275 while maintaining a Buy rating, pointing to improving free cash flow and management's emphasis on quality and stability as production ramps. Boeing reported a robust fourth quarter with earnings and revenue that beat expectations, prompting several other analysts to raise their targets.

Key Points

  • UBS raises Boeing price target to $285 from $275 and maintains a Buy rating; stock trading at $244.56 with analyst targets ranging from $155 to $300.
  • UBS cites improving free cash flow and management focus on quality and stability as production increases to meet demand; UBS models 2030 free cash flow at $20 billion (~$25 per share).
  • Boeing reported strong Q4 2025 results - EPS $9.92 vs expected loss of $0.45, revenue $23.9 billion vs expected $22.4 billion, total sales $24 billion (up 57% vs strike-affected Q4 2024) and free cash flow of about $400 million; other analysts also raised targets.

UBS updated its valuation outlook for Boeing, raising the firm's price target to $285.00 from $275.00 and keeping a Buy rating on the aerospace company. The stock is trading at $244.56, with analyst targets reported to span a range from $155 to $300.

In its note, UBS highlighted improving free cash flow as a core reason for the higher target. The bank emphasized Boeing's continued focus on quality and operational stability while it scales commercial aircraft production to respond to strong demand. UBS framed these priorities as central to restoring investor confidence as the company grows output.

UBS also called attention to Boeing's gross profit margins, which are currently weak at 4.79%. The bank suggested that the company's quality-first approach is particularly important given the margin backdrop, and that progress on these fronts should support a reorientation of investor valuation toward normalized free cash flow metrics.

Management transparency was singled out by UBS as another constructive development. The bank said greater disclosure should help shift market attention toward valuing Boeing on normalized free cash flow, conditional on the company continuing to make steady progress on execution.

On forward guidance, Boeing has outlined a path to positive free cash flow in 2026 and a bridge to high single-digit billions in positive free cash flow this year. UBS noted that these company projections incorporate build rates and unit cash margins that the bank described as "far below" what it thinks is feasible, implying UBS expects stronger operational performance could lift cash generation beyond current guidance.

Looking further ahead, UBS provided a 2030 free cash flow estimate for Boeing of $20 billion, which the bank equated to roughly $25 per share. UBS said the stock has already undergone a re-rating but that there remains "material upside" to consensus free cash flow expectations if Boeing continues to execute well.

Boeing's recent operating results provided empirical support for the more optimistic tone. For the fourth quarter of 2025 the company reported earnings per share of $9.92, materially above the expected loss of $0.45. Revenue for the quarter was $23.9 billion, topping the expected $22.4 billion. Total sales were reported at $24 billion, a 57% increase compared with the strike-affected fourth quarter of 2024. Free cash flow for the quarter was also better than anticipated, at approximately $400 million.

Analysts responded to the results and operational progress with price target increases. RBC Capital raised its target to $275 while maintaining an Outperform rating. TD Cowen raised its target to $270 and kept a Buy rating, while noting a $565 million charge related to the KC-46 program. Vertical Research Partners set a new target of $281, citing operational stabilization and resolution of key portfolio issues as signs of recovery. Collectively, these updates reflect rising analyst confidence in Boeing's financial and operational trajectory.


These developments come as Boeing balances production increases with a push for higher quality and stronger cash generation. The market reaction and analyst adjustments indicate a reassessment of the company's path back to normalized, multi-year free cash flow generation.

Risks

  • Boeing's reported gross profit margins are weak at 4.79%, which underscores margin sensitivity and the need for quality-driven improvements - impacting aerospace sector margins and investor valuations.
  • A $565 million charge related to the KC-46 program was noted by TD Cowen, representing program-specific cost risks that affect Boeing's defense portfolio and near-term profitability.
  • UBS's upside case depends on management maintaining steady progress and execution; if transparency or execution falters, market valuation could remain tied to lower normalized free cash flow assumptions, affecting aircraft manufacturers and related suppliers.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026